JP2024514203A5 - - Google Patents
Info
- Publication number
- JP2024514203A5 JP2024514203A5 JP2023563211A JP2023563211A JP2024514203A5 JP 2024514203 A5 JP2024514203 A5 JP 2024514203A5 JP 2023563211 A JP2023563211 A JP 2023563211A JP 2023563211 A JP2023563211 A JP 2023563211A JP 2024514203 A5 JP2024514203 A5 JP 2024514203A5
- Authority
- JP
- Japan
- Prior art keywords
- icd
- zeta signaling
- cells
- dap12
- signaling domains
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163174990P | 2021-04-14 | 2021-04-14 | |
| US63/174,990 | 2021-04-14 | ||
| PCT/US2022/024842 WO2022221548A1 (en) | 2021-04-14 | 2022-04-14 | Chimeric antigen receptors to target cd5-positive cancers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024514203A JP2024514203A (ja) | 2024-03-28 |
| JP2024514203A5 true JP2024514203A5 (https=) | 2025-02-21 |
Family
ID=83640731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023563211A Pending JP2024514203A (ja) | 2021-04-14 | 2022-04-14 | Ｃｄ５陽性がんを標的とするキメラ抗原受容体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240189357A1 (https=) |
| EP (1) | EP4322992A4 (https=) |
| JP (1) | JP2024514203A (https=) |
| KR (1) | KR20240007911A (https=) |
| CN (1) | CN117480187A (https=) |
| AU (1) | AU2022259658A1 (https=) |
| BR (1) | BR112023021133A2 (https=) |
| CA (1) | CA3216557A1 (https=) |
| IL (1) | IL307408A (https=) |
| MX (1) | MX2023012180A (https=) |
| WO (1) | WO2022221548A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102831183B1 (ko) * | 2021-04-29 | 2025-07-09 | 한국생명공학연구원 | 신규한 항-cd5 키메릭 항원 수용체 및 이를 발현하는 면역세포 |
| EP4419128A4 (en) * | 2021-10-20 | 2025-10-01 | Univ Texas | NK CELL ENGINEERING WITH CAR CONSTRUCTION WITH OPTIMAL SIGNALING |
| JP2024539129A (ja) * | 2021-10-21 | 2024-10-28 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 増強された代謝適合性を有する治療用免疫細胞の製造方法およびその組成物 |
| WO2024249728A2 (en) * | 2023-06-02 | 2024-12-05 | Board Of Regents, The University Of Texas System | Selection of cryopreserved cord blood units for the manufacture of natural killer cells with enhanced potency |
| WO2025038813A1 (en) * | 2023-08-16 | 2025-02-20 | Beam Therapeutics Inc. | Cd5-binding polypeptides, compositions comprising the same, and methods for use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7237449B2 (ja) * | 2015-02-27 | 2023-03-13 | アイセル・ジーン・セラピューティクス・エルエルシー | 血液系腫瘍を標的としたキメラ抗体受容体（ＣＡＲｓ）の構成およびその使用方法 |
| US10786549B2 (en) * | 2015-04-23 | 2020-09-29 | Baylor College Of Medicine | CD5 chimeric antigen receptor for adoptive T cell therapy |
| AU2016274989A1 (en) * | 2015-06-12 | 2017-11-02 | Immunomedics, Inc. | Disease therapy with chimeric antigen receptor (car) constructs and t cells (car-t) or nk cells (car-nk) expressing car constructs |
| WO2017112877A1 (en) * | 2015-12-22 | 2017-06-29 | Icell Gene Therapeutics, Llc | Chimeric antigen receptors and enhancement of anti-tumor activity |
| EP3567101A4 (en) * | 2017-01-05 | 2020-12-02 | Korea Research Institute of Bioscience and Biotechnology | NATURAL KILLER CELL EXPRESSING AN ANTI-COTININ CHEMERIC ANTIGEN RECEPTOR |
| CA3070998A1 (en) * | 2017-07-25 | 2019-01-31 | Board Of Regents, The University Of Texas System | Enhanced chimeric antigen receptors and use thereof |
| US20230159618A1 (en) * | 2017-07-25 | 2023-05-25 | Board Of Regents, The University Of Texas System | Enhanced chimeric antigen receptors and use thereof |
-
2022
- 2022-04-14 CA CA3216557A patent/CA3216557A1/en active Pending
- 2022-04-14 AU AU2022259658A patent/AU2022259658A1/en active Pending
- 2022-04-14 EP EP22788946.6A patent/EP4322992A4/en active Pending
- 2022-04-14 WO PCT/US2022/024842 patent/WO2022221548A1/en not_active Ceased
- 2022-04-14 US US18/552,727 patent/US20240189357A1/en active Pending
- 2022-04-14 KR KR1020237039102A patent/KR20240007911A/ko active Pending
- 2022-04-14 BR BR112023021133A patent/BR112023021133A2/pt unknown
- 2022-04-14 JP JP2023563211A patent/JP2024514203A/ja active Pending
- 2022-04-14 CN CN202280042176.6A patent/CN117480187A/zh active Pending
- 2022-04-14 MX MX2023012180A patent/MX2023012180A/es unknown
- 2022-04-14 IL IL307408A patent/IL307408A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024514203A5 (https=) | ||
| US20220370501A1 (en) | Methods for enhancing efficacy of therapeutic immune cells | |
| JP7258364B2 (ja) | がんおよび関連悪性腫瘍の治療のためのγδＴ細胞を活性化、修飾、および増殖させる方法 | |
| JP2024138280A5 (https=) | ||
| Li et al. | Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy | |
| Redeker et al. | Improving adoptive T cell therapy: the particular role of T cell costimulation, cytokines, and post-transfer vaccination | |
| JP2018500944A5 (https=) | ||
| Chiriva‐Internati et al. | Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno‐associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells | |
| Murad et al. | Manufacturing development and clinical production of NKG2D chimeric antigen receptor–expressing T cells for autologous adoptive cell therapy | |
| JP2023539361A5 (https=) | ||
| JP2022550899A5 (https=) | ||
| JP2018522567A5 (https=) | ||
| JP2021514665A5 (https=) | ||
| JP2022542399A5 (https=) | ||
| JP2024525609A5 (https=) | ||
| JP2021525534A5 (https=) | ||
| JP2021518149A5 (https=) | ||
| JP2018531022A (ja) | 改変ヒト初代血液樹状細胞株を生成するための方法 | |
| JP2024527879A5 (https=) | ||
| Yu et al. | Revolution of CAR engineering for next-generation immunotherapy in solid tumors | |
| Lv et al. | γδT cells, a key subset of T cell for cancer immunotherapy | |
| JP2022513164A5 (https=) | ||
| Dörrie et al. | Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes | |
| EP4349969A1 (en) | Composition containing feeder cell for proliferating natural killer cell | |
| CA3234822A1 (en) | Methods for culturing cells expressing ror1-binding protein |